Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of JAB-8263 in active rheumatoid arthritis
CTR20262325Phase 2Active
- Sponsor
- Jacobio Pharmaceuticals
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jab-8263 in rheumatoid arthritis (RA), sponsored by Jacobio Pharmaceuticals. Started Jul 2026; status: active.
02
Drugs
jab-8263
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20262325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262325.